New hope for advanced colon cancer: experimental drug combo enters major trial
NCT ID NCT07462143
First seen Mar 11, 2026 · Last updated May 12, 2026 · Updated 8 times
Summary
This study tests whether a new drug called RC148, combined with chemotherapy, works better than the standard treatment (bevacizumab plus chemo) for people with advanced colorectal cancer that cannot be removed by surgery or has spread. About 700 adults aged 18-75 will take part. The goal is to see if the new combination shrinks tumors more effectively and safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL (COLON OR RECTAL) CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Jiangnan University
Wuxi, Jiangsu, China
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, China
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
-
Chongqing Cancer Hospital
Chongqing, Chongqing Municipality, China
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
-
Guangxi Medical University Cancer Hospital
Nanjing, Guangxi, China
-
Jiangsu Cancer Hospital
Nanjing, Jiangsu, China
-
Meizhou People's Hospital
Meizhou, Guangdong, China
-
People's Hospital of Tianjin
Tianjin, Tianjin Municipality, China
-
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
-
Shanxi Cancer Hospital
Taiyuan, Shanxi, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
-
The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital
Shijiazhuang, Hebei, China
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
The first hospital of Jilin University
Changchun, Jilin, China
-
Tongji Medical College of Huazhong University of Science &Technology
Wuhan, Hubei, China
-
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
-
West China Hospital of Sichuan University
Chengdu, Sichuan, China
-
Yunnan Cancer Hospital
Kunming, Yunnan, China
Conditions
Explore the condition pages connected to this study.